Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer. [electronic resource]
Producer: 20171103Description: 1006-21 p. digitalISSN:- 2159-8290
- Animals
- Antineoplastic Agents -- chemistry
- Cell Line, Tumor
- Cell Transformation, Neoplastic -- genetics
- Chromatin -- genetics
- Disease Models, Animal
- Drug Design
- Enhancer Elements, Genetic
- Enhancer of Zeste Homolog 2 Protein -- antagonists & inhibitors
- Gene Expression
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lung Neoplasms -- diagnosis
- Magnetic Resonance Imaging
- Mice
- Models, Molecular
- Molecular Conformation
- Molecular Targeted Therapy
- Promoter Regions, Genetic
- Structure-Activity Relationship
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.